BeStock  
Stocks › Diagnostics & Research › DGX

Quest Diagnostics DGX

US equityMarket cap rank #489Diagnostics & ResearchInfectious DiseaseCROMpox (monkeypox)
$231.60 −$1.47 (-0.63%)
Market open · Oct 1, 1:20 pm ET · After hours $233.07 0.00%
Open$232.58
Prev close$233.07
Day range$231.11 – $233.33
Volume418.2K
Market cap$25.56B
P/E (TTM)24.6
Dividend yield1.06%

DGX Stock News

Headlines matching Quest Diagnostics or the DGX ticker, most recent first.

  • UBS Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $245Market news · 8 Sep 2026
  • Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $250Market news · 23 Sep 2026
  • Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $260Market news · 22 Sep 2026
  • Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $260Market news · 21 Sep 2026
  • Quest Diagnostics(DGX.US) Officer Sells US$5.51 Million in Common StockMarket news · 1 Sep 2026
  • Morgan Stanley Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260Market news · 19 Aug 2026
  • Mizuho Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260Market news · 29 Jul 2026
  • Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $250Market news · 29 Jul 2026
  • Argus Research Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $260Market news · 29 Jul 2026
  • J.P. Morgan Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $250Market news · 28 Jul 2026
  • A Quick Look at Today's Ratings for Quest Diagnostics(DGX.US), With a Forecast Between $232 to $265Market news · 25 Jul 2026
  • A Quick Look at Today's Ratings for Quest Diagnostics(DGX.US), With a Forecast Between $232 to $260Market news · 24 Jul 2026
  • Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $230Market news · 16 Jul 2026
  • BofA Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $245Market news · 13 Jul 2026
  • Baird Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $236Market news · 13 Jul 2026

Discussion

No comments yet — be the first to weigh in on DGX.

Leave a comment

Scroll to Top